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Linkage analysis may not provide the necessary resolution for identification of the genes underlying phenotypic
variation. This is especially true for gene-mapping studies that focus on complex diseases that do not exhibit
Mendelian inheritance patterns. One positional genomic strategy involves application of association methodology
to areas of identified linkage. Detection of association in the presence of linkage localizes the gene(s) of interest to
more-refined regions in the genome than is possible through linkage analysis alone. This strategy introduces a
statistical complexity when family-based association tests are used: the marker genotypes among siblings are cor-
related in linked regions. Ignoring this correlation will compromise the size of the statistical hypothesis test, thus
clouding the interpretation of test results. We present a method for computing the expectation of a wide range of
association test statistics under the null hypothesis that there is linkage but no association. To standardize the test
statistic, an empirical variance-covariance estimator that is robust to the sibling marker-genotype correlation is
used. This method is widely applicable: any type of phenotypic measure or family configuration can be used. For
example, we analyze a deletion in the A2M gene at the 5′ splice site of “exon II” of the bait region in Alzheimer
disease (AD) discordant sibships. Since the A2M gene lies in a chromosomal region (chromosome 12p) that con-
sistently has been linked to AD, association tests should be conducted under the null hypothesis that there is linkage
but no association.
Introduction
Although linkage analysis has been applied successfully
to the mapping of genes involved in the pathogenesis of
diseases exhibiting Mendelian inheritance, its applica-
tion in the setting of genetically complex diseases has
been less fruitful (Risch and Merikangas 1996). With
complex diseases, the resolution from linkage analysis
is reduced, and extended segments of the genome con-
taining large numbers of genes may be implicated in
disease etiology (Hauser and Boehnke 1997; Roberts et
al. 1999). Fine mapping of these linked regions may be
accomplished through the use of allelic-association
methods that are designed to jointly detect linkage and
gametic-phase disequilibrium. Detecting association sig-
nificantly refines the search for disease susceptibility
genes, because linkage disequilibrium between a genetic
marker and disease susceptibility polymorphisms is ex-
pected to exist only over relatively small genetic dis-
tances in most populations. The sequential approach of
linkage-based genomic screening followed by dissection
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of linked regions with association methodology recently
has been used to identify a susceptibility locus for human
hypertension (Bray et al. 2000).
Allelic association can be detected through traditional
contingency-table analysis using cases and controls
(Woolf 1955). Although straightforward to implement,
tests based on this approach are sensitive to spurious
association caused by population admixture (Ott 1989).
Family-based association tests (FBATs) are a class of
tests that utilize within- and between-family marker-
inheritance patterns to test for association and that are
safeguarded, by design, from confounding caused by
admixture (Ewens and Spielman 1995). A widely used
FBAT is the transmission/disequilibrium test (TDT; Ter-
williger and Ott 1992; Spielman et al. 1993), which uses
the marker genotypes of an affected child and those of
his/her parents to test for association. FBATs have re-
ceived much attention lately, with numerous extensions
and generalizations of the TDT being proposed in the
literature. Recently, Rabinowitz and Laird (2000) de-
veloped a unified approach to family-based association
tests that puts tests of different genetic models, tests of
different sampling designs, tests involving different dis-
ease phenotypes, tests with missing parents, and tests
of different null hypotheses, all in the same framework.
Algorithms for calculating the distribution of associa-
tion test statistics for these many settings are also
presented.
A distinction must be made between tests for linkage
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that use association methods and tests for association
in the presence of linkage. Letting v be the recombi-
nation parameter and d be a measure of allelic associ-
ation, the tests for linkage that use association methods
have a composite null hypothesis (type I ) that canH0
be expressed as or . The null hypoth-H :d p 0 v p 1/20
esis for testing association in the presence of linkage
(type II ) is and . Both settings haveH H :d p 0 v ! 1/20 0
the same alternative hypothesis, and .H :d 1 0 v ! 1/2a
Complications arise in tests addressing the type II H0
setting, because sibling marker genotypes are correlated
under (Martin et al. 1997; Lazzeroni and LangeH0
1998). Ignoring the correlation in the type II settingH0
compromises the a level of the tests. In this article, we
show that valid tests for association in the presence of
linkage may be performed using the mean of the test
statistic computed via the Rabinowitz-Laird (RL) al-
gorithm for the type I setting and an empirical var-H0
iance-covariance estimator that adjusts for the corre-
lation among sibling marker genotypes. This provides
a convenient means for testing allelic association in the
presence of linkage that can be used with a wide range
of test statistics and any pedigree configuration. For
example, the nine strategies for testing the type I H0
advocated by S. Horvath, X. Xu, and N. Laird (un-
published data), which include applications to binary,
quantitative and time-to-onset phenotypes, can all be
adapted to the type II setting with the method pre-H0
sented here. We note that in the biallelic setting and
with a qualitative trait, the pedigree disequilibrium test
(PDT; Martin et al. 2000c) is similar to the approach
developed here.
As an illustration, we focus on the reported associ-
ation between alleles of the A2M gene and late-onset
Alzheimer disease. Blacker et al. (1998) reported a
strong association between a deletion near the 5′ splice
site of exon 18 of the A2M gene (A2M-18i) and AD in
a sample of sibships from the National Institute ofMen-
tal Health (NIMH) Genetics Initiative (Blacker et al.
1997). During the course of the A2M association study,
linkage to a nearby region on chromosome 12 was re-
ported as part of a genome screen (Pericak-Vance et al.
1997). Subsequent linkage analyses revealed linkage
peaks at or near the A2M gene (Rimmler et al. 1997;
Rogaeva et al. 1998; Wu et al. 1998; Kehoe et al. 1999;
Scott et al. 1999). The reported A2M association has
been controversial, with further findings both confirm-
atory and nonconfirmatory (Dow et al. 1999; Rogaeva
et al. 1999; Rudrasingham et al. 1999; Romas et al.
2000). In any case, A2M is useful as an illustration of
association tests conducted in the presence of linkage.
We use the NIMH data set, in which a strong A2M/AD
association has been reported (Blacker et al. 1999), to
illustrate our method.
FBATs
We assume that there are N nuclear families, with ni
children in each family. Let be the marker genotypemij
for the jth child in the ith family and be the vectormi
of marker genotypes for the children in the ith family.ni
In addition, the vector of parental marker genotypes will
be denoted by . Let be an vector thatM X(m ) h # 1i ij
codes for marker genotype. Depending on the coding
scheme, may be a scalar or a vector (see SchaidX(m )ij
1996; Laird et al. 2000; S. Horvath, X. Xu, and N. Laird
[unpublished data]). Last, let be the phenotype of theyij
jth child in the ith family and be some function ofT(y )ij
the phenotype. In what follows we will often abbreviate
with and with and drop the subscriptX(m ) X T(y ) Tij ij ij ij
indicating family when dealing with data from only one
family.
Association test statistics are constructed to detect
correlation between genotype and phenotype. In this
article, we restrict attention to the class of test statistics
that can be expressed as
S p S p T X , (1) i ij ij
i i j
where the summation is over all children in all families
and is the contribution from the ith nuclear family,Si
. Test statistics in this general class consti-i p 1,… ,N
tute the majority of family-based association test sta-
tistics proposed in the literature, including tests in the
multiallelic setting, tests using quantitative phenotypes,
and tests that allow missing parental marker informa-
tion (Laird et al. 2000; Rabinowitz and Laird 2000).
For example, with simplex families, letting be anTij
indicator function for child disease status and be theX ij
count of a particular marker allele, counts the totalSi
number of alleles in the affected child and is the sameS
test statistic used in the TDT. Other types of test sta-
tistics are discussed in S. Horvath, X. Xu, and N. Laird
(unpublished data).
Under the assumption that the N families are un-
related, the distribution of the test statistic underS
depends on the distributions of the independentH0
, . For the ith family, the general distri-S i p 1,… ,Ni
bution of depends on the joint distribution of theSi
observed children’s marker genotypes, children’s phe-
notypes, and parental marker genotypes .p(m ,M ,y)i i i
Under the type I , depends on alleleH p(m ,M ,y)0 i i i
frequencies and the genetic model; conditioning on
the phenotypes and the parental genotypes eliminates
these unknown nuisance parameters and makes the
distribution of dependent only on the conditionalSi
distribution of the children’s marker genotypes (Laz-
zeroni and Lange 1998). When parental genotypes
are unknown, the nuisance parameters can be elim-
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inated by conditioning on the sufficient statistic for
the parental genotypes , which is composed ofS(M)
the observed parental genotypes (when available)
and the children’s genotype configurationM Cobs m
(Rabinowitz and Laird 2000). The distribution under
the type II is discussed in the next section.H0
Using the conditional distribution of the children’s
marker genotypes, we take the approach of standard-
izing and using the large sample normal or x2 ap-S
proximation. In this case, the mean and variance of the
are required. For the type I , lettingS H F pi 0 I
, S. Horvath, X. Xu, and N. Laird (unpublished[S(M),y]
data) show that can be computed with the uni-E(SFF )i I
variate conditional distribution of the children’s marker
genotype, and can be computed with the uni-Var(SFF )i I
variate and bivariate conditional distributions of the
children’s marker genotypes, where refers to theVar(7)
variance-covariance matrix. That is, by using just the
joint distributions of (which, under the type I(m ,m )ij ik
, do not depend on j and k), we can computeH0
. These distributions can be computed usingVar(SFF )i I
the RL algorithm for the type I .H0
Tests of Association in the Presence of Linkage
As discussed above, association tests performed in areas
of known linkage may significantly refine gene-mapping
studies. The challenge is that, among siblings, genetic
markers that reside within linked regions are correlated
even in the absence of association and after conditioning
on . The dependence exists because sib-F p [y,S(M)]I
lings with similar phenotypes are more likely to share
the putative disease genes, even in the absence of allelic
association. Linkage between a marker and the putative
disease gene, therefore, induces positive correlation be-
tween the genetic markers of siblings with similar phe-
notypes. The opposite holds for siblings with disparate
phenotypes. The correlation makes dependentp(mFF )I
on the recombination parameter and the genetic model
for the phenotype.
Conditioning on the minimal sufficient statistic for
v and the phenotypes removes the dependence of the
marker genotypes on v and under the type II .y H0
When the patterns of allele sharing among siblings
can be unambiguously determined, they serve as the
minimal sufficient statistic for v (Rabinowitz and
Laird 2000). With incomplete identification of the
allele sharing patterns, the outcome space of the chil-
dren’s marker genotypes given the minimal sufficient
statistic under the type II may be computed usingH0
the RL algorithm (type II case). Therefore, underH0
the type II , the minimal sufficient statistic con-H F0 II
sists of the minimal sufficient statistic for the recom-
bination parameter , the minimal sufficient sta-S(v)
tistic for the parental marker genotypes , and theS(M)
observed phenotypes .y
Since patterns of allele sharing are defined by the joint
realization of sibling marker genotypes, the conditional
outcome space consists of the various joint outcomes
of sibling marker genotypes satisfying the constraints
of the minimal sufficient statistic for the type II (Mar-H0
tin et al. 1997; Rabinowitz and Laird 2000). Therefore,
after conditioning on , the convenient expression ofFII
and , in terms of the univariate andE(SFF ) Var(SFF )i II i II
bivariate conditional distribution of marker genotypes
under the type I , cannot be paralleled. Rather, underH0
the type II , expressions for andH E(SFF ) Var(SFF )0 i II i II
using the RL algorithm can be found with the multi-
nomial distribution.
For a given family, assume that there are p compatible
realizations of the sibling marker genotypes, and let r
be a random vector, with the kth element beingp# 1
an indicator function that assumes the value 1, when
the realization of the sibling marker genotypes corre-
sponds to the kth element of the conditional outcome
space, and 0 otherwise. The set of possible outcomes is
given in tables 4–7 in Rabinowitz and Laird (2000) for
nuclear families. Because, under the type II and con-H0
ditional on , all outcomes are equally likely, withFII
probability , follows a multinomial distribution,1/p r
with mean and variance given by
1
m p E(rFF ) p 1r II pp
and
1 1 ′S p Var(rFF ) p I  1 1 ,r II p p p( )p p
where is a vector of 1s and is a di-1 p# 1 I p# pp p
mensional identity matrix.
The moments of can be derived using the momentsSi
of . Let be an matrix with the kth columnrr S h# pi
equal to where is the(k) (k) (k) (k) T X(m ) m p (m ,… ,m )j ij ij i1 ini
vector of sibling marker genotypes corresponding to the
kth element of the conditional outcome space and h is
the length of the marker genotype coding vector . TheX
conditional mean and variance of areSi
rm p E(SFF ) p S mS i II i ri
and
r r ′S p Var(SFF ) p S S (S ) .S i II i r ii
Under the type II , the approximate distribution ofH0
is .S E(SFF ) N (0, S )II h i Si
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Table 1
Nuclear Family Informativeness for Both Conditioning
Approaches
PARENTAL
GENOTYPESa
CHILDREN
CONFIGURATIONb
FAMILY
INFORMATIVENESS
EV-FBAT
RL Algorithm
Type II H0
AA,AA NA No No
AA,AB NA Yes Yes
AA,BB NA No No
AB,AB NA Yes Yes
AA, {AA} No No
AA, {AA,AB} Yes Yes
AB, {AA} No No
AB, {AB} No No
AB, {AA,AB} Yes No when n 1 2
AB, {AA,BB} Yes Yes
AB, {AA,AB,BB} Yes Yes
, {AA} No No
, {AB} No No
, {AA,AB} Yes No when n 1 2
, {AA,BB} Yes Yes
, {AA,AB,BB} Yes Yes
a  p Not genotyped.
b NA p not applicable.
The last column of table 1 indicates which combi-
nations of parental marker genotypes and children
marker configurations are potentially informative in the
biallelic setting with the RL algorithm applied to the
type II setting. When parental data are missing (asH0
is often the case for late-onset diseases), sibships with
more than two sibs and orC p {AA,AB} C pm m
are not informative, because allele sharing can-{BB,AB}
not be discerned. The removal of these types of sibships
may cause a substantial loss in the effective sample size,
especially when one of the alleles is rare, because ho-
mozygotes of the rare allele will be infrequent. An al-
ternative to conditioning on the allele sharing is to take
advantage of the linear form of the test statistic (eq. [1])
and to use the RL algorithm for the type I to calculateH0
the expectation, in conjunction with a robust variance-
covariance estimator. The development of this approach
follows.
Factorization of under Type IIp(mFF ) HI 0
In view of the potentially severe loss of information
caused by conditioning on sibling identical-by-descent
(IBD) patterns, we here develop a method that employs
the type I RL algorithm to compute NH  S 0 ip1 i
and an empirical variance-covariance estimatorE(SFF )i I
that is robust to the correlation among the sibling
marker genotypes. To show that is aN S  E(SFF )ip1 i i I
valid measure of association in the presence of linkage,
we derive the marginal conditional distribution for the
kth sibling marker genotype and show that thisp(m FF )k I
marginal distribution is the same under both the type I
and the type II and does not depend on the re-H H0 0
combination parameter v or on the observed phenotypes
for (see Appendix). Since the linear formy k p 1,… ,n
of the test statistic (eq. [1]) permits its expectation to be
found using , the RL algorithm for the type Ip(m FF )k I
can be used to compute . Therefore, withoutH E(SFF )0 i I
specification or estimation of v and without parameter-
ization of the phenotype distribution, can beS E(SFF )I
used to construct an unbiased test for association in the
presence of linkage. Since family-specific contributions
comprise , only the variances of these con-S E(SFF )I
tributions are needed to compute ; theVar[S E(SFF )]I
correlation among children need not be addressed when
finding .Var[S  E(SFF )]i i I
The derivation in the Appendix employs an ordered
notation similar to that of Thomson (1995), where
is the marker genotype of the kth child, expressed∗mk
in terms of the parental derived haplotypes (see Appen-
dix). In particular, it is shown that under both the type
I and the type II , the joint conditional probabilityH H0 0
for a family can be factored into
Pr (mFF ) p Pr (m Fm ,M,y)I k k
M Au
∗ Pr (m ,M)∗m B kk# ,[ ]S(M)
where is the vector of sibling marker alleles withmk
the kth sibling information omitted, is the unob-Mu
served parental marker genotypes, is the set of unob-A
served parental maker genotypes that coincide with
and corresponds to the set of paternal and ma-S(M) B
ternal derived markers for parents with marker geno-
types that result in the kth sibling’s observed markerM
genotype . Marginalization of with respectm Pr (mFF )k I
to results in the marginal conditional probabilitymk
for the kth sibling marker genotype with Pr (m FF ) pk I
. In addition, we show that isPr [m FS(M)] Pr [m FS(M)]k k
not a function of v and can be computed using the RL
algorithm for the type I . Although the factoriza-H0
tion can be used to find the correct conditional expecta-
tion of the test statistic, it cannot be used to derive ex-
pressions for the covariance between sibling marker
genotypes, because it marginalizes over the IBD
relationships.
Since are independent mean 0 randomS  E(SFF )i i I
vectors with unspecified variance-covariance matrices,
we can apply the results of White (1980) to construct
a robust variance-covariance estimator of .S E(SFF )I
Specifically, White (1980) addresses estimation of the
variance-covariance matrix for estimated regression pa-
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Table 2
A2M/Alzheimer Disease Association Test Results for
Various Methods
Method
No. of
Informative
Sibships 2x P
Type I RL algorithm 51 8.599 .0034
Type II RL algorithm 10 6.125 .0133
EV-FBAT 44 8.631 .0033
Siegmund et al. (2000) 51 6.916 .0085
PDT 50 8.387 .0038
SDT 46 … .0016
rameters in linear models with heteroscedastic errors.
The test statistic can be couched as pro-S E(SFF )i I
portional to a vector of parameter estimates from a
linear model and, therefore, the White empirical vari-
ance-covariance estimator, given by
N
ˆˆS p Var [S  E(SFF )]W i i I{ }
ip1
N
′p [S  E(SFF )][S  E(SFF )] , (2) i i I i i I
ip1
provides a consistent estimate of the variance-covari-
ance matrix of . Alternatively, can be de-ˆS E(SFF ) SI W
rived using the results of Liang and Zeger (1986) on
generalized estimating equations. When is vector-val-S
ued, may not be full rank. In this case, the test statisticˆS
for the type II is , where′ ˆH [S E(SFF )]S [S E(SFF )]0 I W I
is the generalized inverse of . It should be notedˆ ˆS SW W
that the empirical variance-covariance estimator (2) re-
duces to a simple sum of squares for the biallelic case.
Extensions to more-complex pedigrees are straight-
forward. Assume that the ith pedigree can be split into
nuclear families, for , and letq i p 1,… ,Fi
F qi
S E(SFF ) p [S  E(S FF )] ,I ij ij I
ip1 jp1
where is the test-statistic contribution from the jthSij
nuclear family in the ith pedigree and is com-E(S FF )ij I
puted using formulas by S. Horvath, X. Xu, and N.
Laird (unpublished data). Although the contributions
from nuclear families in the same pedigree are not in-
dependent, we can again appeal to White (1980) to
construct a consistent estimate of the variance-covari-
ance matrix of :S E(SFF )I
′
F q qi i
ˆS p S  E(S FF ) S  E(S FF ) .  W ij ij I ij ij I[ ][ ]ip1 jp1 jp1
The advantage of the empirical variance-covariance
approach is that more nuclear-family marker configu-
rations are informative than is the case with the type II
conditioning method. Table 1 indicates which nuclear
family configurations are informative for the two ap-
proaches in the setting of a biallelic marker. In addition,
since the conditioning is different for the two ap-
proaches, the expected values and variance-covariance
terms are also not the same. We will refer to the em-
pirical variance-covariance approach as “EV-FBAT.”
Example: Testing for Association in the A2M Gene
As an example, we tested for association between the
A2M-18i deletion and AD in a set of sibships from the
National Institute of Mental Health (NIMH) Genetics
Initiative AD Sample. The ascertainment and assessment
of the AD families collected have been discussed else-
where (Blacker et al. 1997). The sample we used is com-
posed of 437 individuals in 120 sibships and is identical
to the sample analyzed by Blacker et al. (1999); 246 of
the siblings met the NINCDS/ADRDA criteria for AD
and/or had autopsy confirmation of the diagnosis.
Table 2 contains the results for testing the A2M-18i/
AD association. The test statistic used in the applica-
tions of the RL algorithm is the sum of theA2M-1 alleles
in AD-affected siblings. This corresponds to the follow-
ing coding schemes:
1 if sibling j in ith sibship is affected
T pij {0 otherwise
and
2 if m p A2M-1/A2M-1ij
X p 1 if m p A2M-1/A2M-2 .ij ij{0 otherwise
Implementation of the RL algorithm consists of finding
the expected value of conditional on the minimalXij
sufficient statistic corresponding to the null hypothesis.
Variance estimation is accomplished through the pro-
cedures described above.
Application of the RL algorithm to test for linkage
and association (type I ) results in 51 informativeH0
sibships and a significant finding. As discussed above,
the type I may not be appropriate in view of theH0
reported linkage evidence in the region spanning the
A2M gene. Conditioning on the type II minimalH0
sufficient statistic results in a dramatic decrease in the
effective sample size. With only 10 informative sibships,
the test statistic is only marginally significant, and its
large sample x2 approximation may not be reliable (ta-
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Figure 1 Empirical significance levels under the type II forH0
average number of informative sibships. The dashed lines are the point-
wise 95% Monte Carlo sampling error levels (0.0457, 0.0543).
ble 2). With EV-FBAT, 44 sibships were informative
resulting in a highly significant result ( ,2x p 2.94
).P p .0033
The discrepancy in the number of informative families
is a consequence of the absence of parental genotype data
and the distribution of genotypes among the siblings
[ , andp(A2M-1/A2M-1) p .732 p(A2M-1/A2M-2) p
, ]. The 34 families that.231 p(A2M-2/A2M-2) p .037
are informative for EV-FBAT but not informative for the
type II conditioning approach have more than twoH0
siblings and orC p {A2M-1/A2M-1, A2M-1/A2M-2}m
as the siblingC p {A2M-2/A2M-2, A2M-1/A2M-2}m
marker configuration. As indicated by table 1, these sib-
ships are not informative for the type II RL approachH0
because no definite allele sharing can be discerned. Be-
cause it does not condition on the allele sharing, the
empirical variance approach is not subject to these con-
straints. The difference between the number of infor-
mative families for the type I RL test and for EV-H0
FBAT is a result of the definition of the empirical variance
(2). Families with do not contribute to theS p E(SFF )i i I
test statistic or the empirical variance-covariance
estimate.
To justify the EV-FBAT x2 approximation with 44
informative sibships, we empirically estimated the sig-
nificance level under the type II for various numbersH0
of informative sibships. We simulated sibships that were
similar to theNIMH sibships in that the size distribution
of the sibships was maintained, the biallelic marker had
population allele frequencies of 0.20 and 0.80, and the
baseline prevalence was fixed at 0.30. Because simulated
data with the same number of sibships will have dif-
ferent numbers of informative families, we report the
mean number of informative families. For each number
of sibships we simulated 10,000 data sets. In figure 1,
the circles represent the empirical significance levels for
the mean number of informative families. The dashed
lines are the pointwise 95% Monte Carlo sampling-
error levels (0.0457, 0.0543). Figure 1 shows that the
empirical significance level is within Monte Carlo sam-
pling error for a large range of informative sibships.
Indeed, the x2 approximation appears to hold even for
samples with only 20 informative sibships. With !20
informative sibships, the test appears to become
conservative.
Robust variance-covariance estimation has been im-
plemented in the context of a TDT extension (TRANS-
MIT; Clayton 1999), conditional logistic regression
(Siegmund et al. 2000), and the PDT (Martin et al.
2000c). All three procedures are limited to qualitative
traits, whereas the application of Siegmund et al. (2000)
is further restricted to discordant sibships. When ap-
plied to the A2M data set, the Wald statistic from con-
ditional logistic regression with robust variance esti-
mation produces a test statistic that is not as
pronounced as that of EV-FBAT but is still significant
(table 2). The PDT produces a test statistic that is es-
sentially equivalent to the test statistic of EV-FBAT in
these data.
Another alternative is to use the sibship disequilib-
rium test (SDT; Horvath and Laird 1998). As shown
in table 2, the SDT provides the strongest evidence
for linkage disequilibrium. The SDT is well suited to
the discordant sibships setting of the NIMH data, but
it is restricted to qualitative phenotypes and cannot
efficiently handle families with genotype-known
parents.
Discussion
One strategy for positional genomic analysis is to focus
allelic-association testing on regions that have been iden-
tified through linkage analysis as putatively containing
a gene or genes influencing phenotypic variation. Sup-
plementing linkage results with associationmethodology
is needed because, with complex diseases, linkage peaks
may span regions of10–20 cM that cover a large num-
ber of genes and are beyond the reach of positional clon-
ing (Hauser and Boehnke 1997). A significant associa-
tion finding may greatly refine the search for the
underlying trait gene, since linkage disequilibrium will
not generally extend over regions 11 cM in outbred pop-
ulations (Pericak-Vance 1998). Although the utility of
association methodology in this setting has been ques-
tioned (Terwilliger and Weiss 1998), the use of associ-
ation methodology in the dissection of a region linked
to human hypertension has recently yielded a suscepti-
bility locus (Bray et al. 2000).
Candidates for the association tests within regions
Lake et al.: FBATs with Linkage 1521
identified by linkage may be chosen via database
searches using knowledge of biological pathways (Broo-
kes et al. 2000). In addition, as dense maps of single-
nucleotide polymorphisms (SNPs) become available and
costs of genotyping decline, the dissection of linked
regions may be accomplished by saturating the linked
regions with SNPs and performing association tests on
them.Martin et al. (2000a, 2000b) have used theAPOE
gene to illustrate the potential for using SNPs in map-
ping studies of complex traits.
With these strategies in mind, we have presented a
method for evaluating the mean and variance-covari-
ance of a wide range of test statistics computed under
the null hypothesis that there is linkage but no associ-
ation (type II ). The method, EV-FBAT, determinesH0
the expected value of an association test statistic by
conditioning on the minimal sufficient statistic under
the null hypothesis of no linkage and no association
(type I ) and uses an empirical variance-covarianceH0
estimator that is consistent even when the sibling
marker genotypes are correlated. As discussed above,
the expectation of the test statistic is computed via the
RL algorithm, and the resulting standardized test sta-
tistic is unbiased as a test for association in the presence
of linkage. In addition, while retaining the robust prop-
erties of family based association tests, EV-FBAT does
not suffer from the costly reduction in sample size
caused by missing parental data that is inherent with
approaches that condition on sibling IBD patterns.
The results of the A2M/AD example strongly suggest
that the A2M-18i deletion is in linkage disequilibrium
with a polymorphism that contributes to AD develop-
ment. Whether or not the A2M-18i polymorphism is
the polymorphism of interest (in which case the linkage
disequilibrium is complete) cannot be deduced by as-
sociation tests. In light of the evidence for linkage, re-
lying on the type I test alone would leave open theH0
interpretation of the P value. Here, the P values of the
type I RL approach and EV-FBAT agree; in general, we
expect the type II P values to be larger if is true.H H0 0
Additional work will investigate the power of EV-FBAT
and various proposed methods under .Ha
For qualitative traits and biallelic markers, EV-FBAT
is similar to the PDT (Martin et al. 2000c). In the PDT,
pedigrees are broken into nuclear families and discor-
dant sibships. Let A and B be the two alleles of the
marker. The contribution to the test statistic of a par-
ticular pedigree consists of weighted sums of the number
of A alleles for each affected child minus an “expected”
number of A alleles. This expectation is computed from
unaffected siblings when the affected child belongs to
a discordant sibship and is computed using a pseudo-
control (as defined by Falk and Rubinstein 1987) when
the affected child belongs to a nuclear family. If a child
belongs to a nuclear family and a discordant sibship,
both differences are computed. Under the type II ,H0
the sum of the pedigree contributions has expectation
0 and is standardized with an empirical estimator of
the variance.
In this setting, the difference between the PDT and
EV-FBAT is in the derivation of the expected number
of A alleles under the type II . In using the RL al-H0
gorithm for the type I , EV-FBAT conditions on theH0
minimal sufficient statistic and, by definition, makes the
most efficient use of the observed data in constructing
the control genotype (see Cox and Hinkley [1974] or
Rabinowitz and Laird [2000]). Further, the PDT can
not use concordant sibships with missing parental
marker information and is also limited to the dichot-
omous-phenotype case.
EV-FBAT uses a robust variance-covariance estima-
tion to take into account the correlation among sibling
marker genotypes under the type II . In addition toH0
the PDT and EV-FBAT, a robust variance-covariance
estimation for the qualitative setting has been imple-
mented in the context of a TDT extension (TRANSMIT;
Clayton 1999) and conditional logistic regression (Sieg-
mund et al. 2000). The method of Clayton (1999) uses
the EM algorithm (Dempster et al. 1977) to impute the
likelihood contribution from family trios in which there
is missing parental information and/or ambiguous ge-
netic transmissions. Such imputation requires a full
specification of the family-trio likelihood that depends
on estimates of allele frequencies and population genetic
assumptions that are difficult to justify. A score test
based on these likelihood contributions is used to test
for association with a robust variance-covariance esti-
mator when multiple siblings are allowed.
The merits of association tests based on conditional
logistic regression have been discussed (Witte et al.
1998; Kraft and Thomas 2000). Siegmund et al. (2000)
recommend generalized estimating equations applied to
the conditional logistic likelihood when the type II H0
is used. Unlike EV-FBAT, this method does not make
any use of available parental data and is restricted to
discordant sibships. As with the PDT, both TRANSMIT
and the Siegmund et al. (2000) procedure are limited
to qualitative traits.
In summary, EV-FBAT provides a flexible framework
for association testing in the presence of linkage because
it can be used with any type of phenotype and with any
pedigree configuration. Therefore, the researcher is not
restricted to particular sampling designs and is free to
test for associations with quantitative or time-to-onset
traits. Indeed, with EV-FBAT, the approaches to asso-
ciation testing with binary, quantitative, and time-to-
onset phenotypes for the type I advocated by S. Hor-H0
vath, X. Xu, and N. Laird (unpublished data) can all
be adapted to the type II . Application of EV-FBATH0
is limited to the class of test statistics that can be ex-
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pressed in a linear form (eq. [1]), but, as discussed in
Laird et al. (2000), a number of family-based associa-
tion-test statistics are of this form. Furthermore, Clay-
ton and Jones (1999) and Lunetta et al. (2000) have
shown that the score statistics from generalized linear
models in which the coded marker genotype is the cov-
ariate can be expressed in the form of equation (1). The
case when the test statistic may depend on unknown
nuisance parameters is discussed in Lunetta et al.
(2000). The method is also valid as a test of the type I
of no linkage or no association, since the empiricalH0
variance-covariance estimator is a consistent estimator
under both types of null hypotheses.
The empirical variance approach for testing associ-
ation in the presence of linkage has been implemented
in a program called FBAT. It is invoked with the -e (for
empirical variance) option for the fbat command. The
program and its documentation are available free of
charge from our Web site. There are different versions
of the program for different operating systems: MAC,
Solaris/Sparc, and Windows. If you encounter prob-
lems, please e-mail fbat@hsph.harvard.edu.
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Appendix A
Proof
We show that, under the type II , the joint conditional distribution of the sibling marker genotypes givenH m0
the sufficient statistic for the parental marker genotypes and the observed phenotypes can be factored intoS(M) y
a form amenable to the approach discussed above. The key point is that the marginal conditional distribution of
a child’s marker genotype is not a function of the recombination parameter v or of the observed phenotypes .y
Therefore, under the type II , the expectation of the test statistic conditional on the minimal sufficient statisticH0
for the type I can be found using the type I RL algorithm, without modeling the correlation between theH H0 0
children’s marker genotypes.
Since , where is the configuration of sibling marker genotypes and is any observedS(M) p (C ,M ) C Mm obs m obs
parental marker genotype, the joint conditional distribution can be expressed as
1Pr [mFS(M),y] p Pr [S(M),y] Pr [m,S(M),y]
1p Pr [S(M),y] Pr (m,C ,M ,y)m obs
1p Pr [S(M),y] Pr (m,M ,y)obs
1p Pr [S(M),y] Pr (m,M,y) ,
M Au S(M)
where is the set of possible unobserved parental marker genotypes with elements that correspond toA MS(M) u
and where .S(M) M p (M ,M )obs u
To derive the marginal conditional distribution of a child’s marker genotype we arbitrarily select the kth sibling
(referred to as the reference sibling) and let be the vector of sibling marker alleles with the kth sibling informationmk
omitted. For all we have thatk p 1,… ,n
Pr (m,M,y) p Pr (m Fm ,M,y) Pr (m ,M,y) .  k k k
M A M Au S(M) u S(M)
We next show that , where is the joint distribution of the sibling phenotypes.Pr (m ,M,y) p Pr (m ,M)f(y) f(y)k k
To do this, we adopt a notation similar to the ordered notation of Thomson (1995), which identifies the paternally
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and maternally derived haplotypes that comprise the marker genotypes of the children. This is accomplished by
expanding the parental marker genotypes into specific haplotypes, , and letting be∗ (p) (p) (m) (m) ∗M p [m /m , m /m ] mi i1 i2 i1 i2 ij
the marker genotype of the jth child expressed in terms of the parental-derived haplotypes. That is, ∗m pij
, where indicate inheritance from each parent. Furthermore, let correspond to the set(p) (m) ′[m /m ] d , d p 1,2 B′ ∗id id j j m ,Mj j k
of paternally and maternally derived markers from parents with marker genotypes that result in the kth sibling’sM
observed marker genotype , and let be the unobserved disease genotypes for the parents(p) (p) (m) (m)m G p [g /g , g /g ]k 1 2 1 2
and be the vector of unobserved disease genotypes for the children. The joint probability, , thus cang Pr (m ,M,y)k
be expressed as the summation
∗Pr (m ,M,y) p Pr (m ,M,y)k k∗m Bk
∗p Pr (y,g,m ,H) , (A1)  k∗m B G gGk
where the additional summations in (A1) are with respect to the set of possible parental disease genotype com-
binations and the set of siblings’ disease genotypes conditional on parental disease genotypes and whereG H p
describes the parental haplotypes.(p) (p) (p) (p) (m) (m) (m) (p)[m g /m g ,m g /m g ]1 1 2 2 1 1 2 2
Under the assumption that sibling disease genotypes are conditionally independent given parental haplotypes,
equation (A1) can be expressed as
∗ ∗f(yFg) Pr (gFH) Pr (g Fm ,H) Pr (m ,H) . (A2)  i k k k[ ]∗ i(km B G gGk
Under the type II null hypothesis of no association, we have that for , and1Pr (gFH) p i p 1,… ,n; i ( ki 4
. Therefore, (A2) can be simplified to∗ ∗Pr (m ,H) p Pr (m ,M) Pr (G)k k
n1
1∗ ∗Pr (m ,M) f(yFg) Pr (g Fm ,H) Pr (G) . (A3)  k k k{ [( ) ] }∗ 4m B G gGk
Let denote the expression within square brackets in equation (A3). There are terms in , corresponding tonF 4 FG G
all the combinations of disease genotypes in the n children. The summation over all combinations of parental
disease genotypes makes the terms in with the same parental disease allele sharing patterns equivalent. ForFG
example, in the case of two children with the first child being the reference sibling,
(p) (m) (p) (m) (p) (m) (p) (m)f{yFg p [g ,g ],g p [g ,g ]} Pr (G) p f{yFg p [g ,g ],g p [g ,g ]} Pr (G) 1 1 1 2 1 2 1 2 1 2 2 2
G G
(p) (m) (p) (m)p f{yFg p [g ,g ],g p [g ,g ]} Pr (G) 1 1 2 2 1 1
G
(p) (m) (p) (m)p f{yFg p [g ,g ],g p [g ,g ]} Pr (G) . 1 2 2 2 2 1
G
Furthermore, if we assume , then we have that∗ (p) (m)m p (m ,m )1 1 1
∗f(yFg ,g ) Pr (g Fm ,H) Pr (G)  1 2 1 1
G gGIBDp1p
(p) (m) (p) (m)p f{yFg p [g ,g ],g p [g ,g ]} Pr (G) , 1 1 1 2 1 2
G
where is the set of disease allele–sharing patterns, between the two siblings, that result in them sharing theGIBDp1p
paternally but not the maternally derived disease allele. Because of the ordered notation, is a simple∗Pr (g Fm ,H)1 1
function of the recombination parameter v, which cancels in the summation.
The same logic can be applied to any disease allele–sharing patterns for any number of children, making it
straightforward to show that . Therefore, , where is not F Pr (G) p f(y) Pr (m ,M,y) p Pr (m ,M)f(y) Pr (m ,M)G G k k k
a function of v or of , and we have the following factorization of the joint conditional distribution:y
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∗ Pr (m ,M)∗m B kkPr [mFS(M),y] p Pr (m Fm ,M,y) ,M A k ku [ ]S(M)
where we have used the fact that, under the type II , . We can marginalize the jointH Pr [S(M),y] p Pr [S(M)] Pr (y)0
distribution with respect to to obtainmk
∗ Pr (m ,M)∗M A,m B ku kPr [m FS(M),y] p . (A4)k S(M)
The term on the right side of (A4) is the conditional distribution of marker genotypes for the kth sibling,
, under the null hypothesis of no linkage and no association. It has been tabulated by Rabinowitz andPr [m FS(M)]k
Laird (2000), for arbitrary missing parental marker information, and can be used to derive under the typeE(SFF )i I
II . In summary, we have shown that is a valid measure of association in the presence of linkage.NH  S  E(SFF )0 ip1 i i I
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